# AHS Investment Corp – FDA Inspection, Feb 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/ahs-investment-corp/ff6f444e-db91-44d4-b4ce-32fa6b9c5b50
Source feed: FDA_Inspections

> FDA inspection 1004655 of AHS Investment Corp, February 27, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004655
- Company Name: AHS Investment Corp
- Inspection Date: 2017-02-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-f-scheraga/7ab7500d-901f-4953-95a7-4a2b22488f04)
- [Company Rep](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)

Company: https://www.keypedia.com/companies/ahs-investment-corp/7d94a139-9cce-4389-af84-be499972338d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c